Market Cap 1.78B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 3,966,000
Avg Vol 6,692,604
Day's Range N/A - N/A
Shares Out 305.38M
Stochastic %K 96%
Beta 1.20
Analysts Strong Sell
Price Target $10.50

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
tradersunion353
tradersunion353 Aug. 5 at 3:23 PM
$ABCL I dont understand why some clowns here who are married to ABCL celebrates when ever this POS drops....
0 · Reply
tradersunion353
tradersunion353 Aug. 5 at 1:34 PM
$ABCL market is sharply up pos is sharply down hope pos management will address leaked bad phase 2 data
3 · Reply
tradersunion353
tradersunion353 Aug. 5 at 12:59 PM
$ABCL clowns already started with their G script we dont care if this crashes on earnings these are the kind of clowns who has been spaming on x and here
1 · Reply
Aswizz
Aswizz Aug. 5 at 12:45 PM
$ABCL we either going way up or way down best of luck to all
3 · Reply
ExploringTrades
ExploringTrades Aug. 5 at 11:24 AM
Ticker NEXR has barely 550,000 shares outstanding. The only comparable ticker was VEEE and that one ran from 4.10$ to over 51$. NEXR released news on Aug 3rd and is shifting heavily into the AI sector. NEXR has only about 700 watchers on Stocktwits. Took a big position looking to profit massively very soon. $ABCL LL
0 · Reply
Plan2TradeTrade2Plan
Plan2TradeTrade2Plan Aug. 5 at 1:29 AM
$ABCL back to $70 on Thursday morning 🚀🚀
0 · Reply
Samb2344
Samb2344 Aug. 5 at 12:58 AM
$ABCL shorts about to get fucked
0 · Reply
tradersunion353
tradersunion353 Aug. 5 at 12:51 AM
$ABCL when was the last time this pos stock benefitted shareholders?? yeah i understand science is great.. but investors needs returns i know some clowns want t just add and no returns 🤮
0 · Reply
tradersunion353
tradersunion353 Aug. 4 at 11:39 PM
$ABCL Guranteed to crash tomorrow after earnings clowns here will spam the board with adding and loading as usual ABCL is cursed biotech for long term investors
3 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 4 at 11:20 PM
$ABCL $ABCL RE: ABCL635 ph2 data readouts in Q3 “This readout has potential to be highly de-risking and to tell us whether or not we are likely to have our first winner.” “We believe this profile [highlighted in purple] would support a product that has blockbuster potential.”
0 · Reply
Latest News on ABCL
AbCellera upgraded to Buy from Hold at Benchmark

2026-07-07T10:35:14.000Z - 4 weeks ago

AbCellera upgraded to Buy from Hold at Benchmark

JAZZ


AbCellera apponts Lynn Seely to board of directors

2026-07-06T13:15:29.000Z - 4 weeks ago

AbCellera apponts Lynn Seely to board of directors

LYEL


AbCellera Appoints Dr. Lynn Seely to its Board of Directors

Jul 6, 2026, 9:00 AM EDT - 4 weeks ago

AbCellera Appoints Dr. Lynn Seely to its Board of Directors


AbCellera appoints Victor Sandor to board of directors

2026-06-05T13:05:56.000Z - 2 months ago

AbCellera appoints Victor Sandor to board of directors


AbCellera Appoints Dr. Victor Sandor to its Board of Directors

Jun 5, 2026, 9:00 AM EDT - 2 months ago

AbCellera Appoints Dr. Victor Sandor to its Board of Directors


AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 3 months ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Slides: Q1 2026


AbCellera initiated with an Overweight at Cantor Fitzgerald

2026-05-05T10:36:31.000Z - 3 months ago

AbCellera initiated with an Overweight at Cantor Fitzgerald


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera initiated with a Buy at JonesResearch

2026-04-09T20:10:26.000Z - 4 months ago

AbCellera initiated with a Buy at JonesResearch


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera reports FY25 EPS (49c) vs. (55c) last year

2026-02-24T21:15:21.000Z - 5 months ago

AbCellera reports FY25 EPS (49c) vs. (55c) last year


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 5 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 7 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 9 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 9 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 11 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 1 year ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Biologics Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q2 2024


AbCellera Biologics Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q2 2024


AbCellera Biologics Slides: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Biologics Quarterly report: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q1 2024


AbCellera Biologics Earnings release: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q1 2024


AbCellera Biologics Slides: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


tradersunion353
tradersunion353 Aug. 5 at 3:23 PM
$ABCL I dont understand why some clowns here who are married to ABCL celebrates when ever this POS drops....
0 · Reply
tradersunion353
tradersunion353 Aug. 5 at 1:34 PM
$ABCL market is sharply up pos is sharply down hope pos management will address leaked bad phase 2 data
3 · Reply
tradersunion353
tradersunion353 Aug. 5 at 12:59 PM
$ABCL clowns already started with their G script we dont care if this crashes on earnings these are the kind of clowns who has been spaming on x and here
1 · Reply
Aswizz
Aswizz Aug. 5 at 12:45 PM
$ABCL we either going way up or way down best of luck to all
3 · Reply
ExploringTrades
ExploringTrades Aug. 5 at 11:24 AM
Ticker NEXR has barely 550,000 shares outstanding. The only comparable ticker was VEEE and that one ran from 4.10$ to over 51$. NEXR released news on Aug 3rd and is shifting heavily into the AI sector. NEXR has only about 700 watchers on Stocktwits. Took a big position looking to profit massively very soon. $ABCL LL
0 · Reply
Plan2TradeTrade2Plan
Plan2TradeTrade2Plan Aug. 5 at 1:29 AM
$ABCL back to $70 on Thursday morning 🚀🚀
0 · Reply
Samb2344
Samb2344 Aug. 5 at 12:58 AM
$ABCL shorts about to get fucked
0 · Reply
tradersunion353
tradersunion353 Aug. 5 at 12:51 AM
$ABCL when was the last time this pos stock benefitted shareholders?? yeah i understand science is great.. but investors needs returns i know some clowns want t just add and no returns 🤮
0 · Reply
tradersunion353
tradersunion353 Aug. 4 at 11:39 PM
$ABCL Guranteed to crash tomorrow after earnings clowns here will spam the board with adding and loading as usual ABCL is cursed biotech for long term investors
3 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 4 at 11:20 PM
$ABCL $ABCL RE: ABCL635 ph2 data readouts in Q3 “This readout has potential to be highly de-risking and to tell us whether or not we are likely to have our first winner.” “We believe this profile [highlighted in purple] would support a product that has blockbuster potential.”
0 · Reply
Rastafari
Rastafari Aug. 4 at 9:33 PM
$ABCL Here’s my Q2 expectation: Revenue should easily surpass the analyst expectations of $8 million, Loss should be reduced, and reiterates that ABCL635 Phase 2 data remain on track for Q3. Biggest surprise is that they announce 635 data and it is positive. If this happens, we bump up over $7 (close at $13) tomorrow. On vertex and jazz revenue we beat the revenue number and that will give us $2-3 dollar bump, closing at ($8-9) for the day! They might also announce a third partner deal! That would be icing on cake!
3 · Reply
snowPOW
snowPOW Aug. 4 at 9:20 PM
$ABCL this one gets my heart rate up... It's for the potential to be a millionaire maker
1 · Reply
JodieChristy
JodieChristy Aug. 4 at 8:43 PM
$ABCL trades at $6.09 (+4.46%). After hitting initial breakout targets and pulling back to test the weekly structure, upcoming earnings make this a tricky read with high implied volatility. Strategy: Reduce size or step aside ahead of the binary earnings event; wait for post-ER clarity. Key support retest zone. Are you playing $ABCL earnings?
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 4 at 8:09 PM
$ABCL I don't want to read too much into this, but Hansen liked this post on LinkedIn discussing the 'biggest spotlight' on AbCellera to deliver human efficacy results this quarter.
1 · Reply
DeMampCamp
DeMampCamp Aug. 4 at 8:01 PM
0 · Reply
TheDrunkTrader69
TheDrunkTrader69 Aug. 4 at 5:08 PM
$ABCL weeeeeeeee
0 · Reply
ExploringTrades
ExploringTrades Aug. 4 at 4:01 PM
Ticker NEXR has barely 550,000 shares outstanding. The only comparable ticker was VEEE and that one ran from 4.10$ to over 51$. NEXR released news on Aug 3rd and is shifting heavily into the AI sector. NEXR has only about 700 watchers on Stocktwits. Took a big position looking to profit massively very soon. $ABCL $FBIO $SNDK $TGTX trend it
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 4 at 3:28 PM
$ABCL $ABCL "If we show that we can get good target engagement in patients, which we'll be able to tell in the early studies using biomarkers, we have an excellent chance of [ABCL635] becoming a drug. In fact...I wouldn't bet against it working in later-stage studies" - Carl Hansen
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 4 at 2:55 PM
$ABCL $ABCL Two major things for tomorrow: 1. Update on the status of ABCL635 — pay attention to the tone 2. New molecule addition to the internal pipeline
1 · Reply
Drewz93
Drewz93 Aug. 4 at 1:59 PM
1 · Reply
Muddy7
Muddy7 Aug. 4 at 1:52 PM
$ABCL An article in todays Globe and Mail regarding Canadian biotech companies including Abcellera....... https://www.theglobeandmail.com/business/article-has-canadas-biotech-moment-finally-arrived/
0 · Reply
tradersunion353
tradersunion353 Aug. 4 at 1:52 PM
$ABCL I have no idea on how these clowns are celebrating for Lost 85% share value in 5 years Company continously pumps about pipelines with almost no value to shareholders. Clowns here are just married to this POS
2 · Reply